<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-77475</identifier>
<setSpec>1576-0952</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Activity of an extracto f purple corneflower against the influenza virus H1N1, H5N1 and H7N7</dc:title>
<dc:description xml:lang="en">Infectionscaused by influenza virases represent a large epidemiological problema Worlwide. Antiviral therapy includes vaccines and few antiviral drugs. However vaccines are not always available in time and viruses develop resistance to neuraminidase inhibitors such as Tamiflu (oseltamivir). We studied the antiviral activity of a commercial standardized extract of Echinacea purpurea (Echinaforce, EF), that demonstrated its ability to inactivate, in cell culture, the influenza viruses H1N1, H5N1 and H7N7, inhibiting the virus binding capacity to the cell receptor and its entry into the cell. Unlike Tamiflu, not only successive incubations with EF did not develop viral resistance, but EF was active against oseltamivir-viruses. In conclusion, this preparation of Echinacea could be a useful addition for the control of replication and spread on influenza virus(AU)</dc:description>
<dc:creator>Hudson, James B</dc:creator>
<dc:creator>Pleschka, Stephan</dc:creator>
<dc:creator>Stein, Michael</dc:creator>
<dc:creator>Schoop, Roland</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Las infecciones producidas por los virus de la influenza (VI) representan un problema de grandes dimensiones epidemiológicas en todo el mundo. La terapia antiviral incluye vacunas y algunos medicamentos antivirales. Sin embargo no siempre se dispone de las vacunas adecuadas y los virus desarrollan resistencia a los inhibidores de la neuraminidasa como Tamiflu (oseltamivir). Se estudió la actividad antiviral de un extracto comercial estandarizado de Echinacea purpurea (Echinaforce, EF), comprobándose su capacidad para inactivar, en cultivos celulares, los virus de la influenza tipo H1N1, H1N5 y H7N7, inhibiendo la capacidad de unión del virus al receptor y su entrada en la célula. A diferencia del Tamifú, no sólo las incubaciones sucesivas con EF no desarrollan resistencias virales, si no que EF fu activo frente a los virus resistentes al oseltamivir. En conclusión, este preparado de equinácea puede constituir un complemento útil para el control de la replicación y difusión de los virus de la influenza(AU)</dc:description>
<dc:source>Rev. fitoter;9(2): 115-124, dic.2009. tab, ilus</dc:source>
<dc:identifier>ibc-77475</dc:identifier>
<dc:title xml:lang="es">Actividad de un extracto de equinácea purpúrea frente a los virus de la influenza H1N1, H5n1 y H7N7</dc:title>
<dc:subject>^d51282^s22038</dc:subject>
<dc:subject>^d52162^s22073</dc:subject>
<dc:subject>^d51282^s22021</dc:subject>
<dc:subject>^d922^s22073</dc:subject>
<dc:subject>^d51286^s22038</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28441</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d51288^s22038</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d26463^s22000</dc:subject>
<dc:subject>^d26463^s22011</dc:subject>
<dc:subject>^d26463^s22073</dc:subject>
<dc:subject>^d51286^s22021</dc:subject>
<dc:subject>^d51288^s22021</dc:subject>
<dc:subject>^d52162^s22000</dc:subject>
<dc:subject>^d52162^s22078</dc:subject>
<dc:type>article</dc:type>
<dc:date>200912</dc:date>
</metadata>
</record>
</ibecs-document>
